4Jarvis WR. Selected aspects of the socioeconomic impact of nosocomial infections : morbidity, mortality, cost and prevention [J]. Infect Control and Hosp Epidemiol, 1996,17:552.
6Van der Kooi TI, Mannin J, Wille JC,et al. Prevalence of nosoco- mial infections in The Netherlands, 2007-2008 : results of the first four national studies[ J]. J Hosp Infect,2010,75 ( 3 ) : 168-172.
7Izquierdo-Cubas F, Zambrano A, Fr6meta I, et al. National Preva- lence of Nosocomial Infections. Cuba 2004 [ J ]. J Hosp Infect, 2008,68 (3) :234-240.
8Durando P, Icardi G, Ansaldi F, et al. Surveillance of hospital- acquired infections in Liguria, Italy:results from a regional preva- lence study in adult and paediatric acute-care hospitals[ J ]. J Hosp Infect ,2009,71 ( 1 ) :81-87.
9Askarian M, Yadollahi M, Assadian O. Point prevalence and risk factors of hospital acquired infections in a cluster of university-affil- iated hospitals in Shiraz, Iran [ J ]. J Infect Public Health, 2012,5 (2) :169-176.
10Dereli N, Ozayar E, Degerli S, et al. Three-Year Evaluation of Nosocomial Infection Rates of the ICU [ J ]. Rev Bras Anesthesiol, 2013,63 ( 1 ) :73-84.
